Skip to content

Medico-economic Comparison of Robot-assisted Radical Prostatectomy Versus Radical Prostatectomy Via Laparotomy

Medico-economic Comparison of Robot-assisted Radical Prostatectomy Using the da Vinci System Versus Radical Prostatectomy Via Laparotomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01577836
Acronym
RoboProstate
Enrollment
90
Registered
2012-04-16
Start date
2012-11-26
Completion date
2021-03-22
Last updated
2025-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostatic Neoplasms

Keywords

Radical prostatectomie, Robotic assistance, Laparotomy

Brief summary

The main objective of the study is to estimate and compare the overall cost of care of patients over 60 months of follow-up between two groups: (1) patients undergoing robot-assisted radical prostatectomy using the Da Vinci system versus (2) patients undergoing robot-assisted radical prostatectomy via laparotomy. The time horizon of the main objective changes to 60 months (due to the opportunity to access patient care consumption from the National Health Data System).

Detailed description

The secondary objectives of this research are to compare the following between the two groups: * The actual cost of the surgical prostatectomy. * Erectile function at 0, 1, 6, 12 and 24 * Oncological results at 1, 6, 12 and 24 months. * Functional results at 0, 1, 6, 12 and 24 months. * Quality of life at 0, 1, 6, 12 and 24 months. * Complication rates at 1 and 24 months.

Interventions

Transperitoneal robot-assisted radical prostatectomy technique with the Da Vinci S

PROCEDURERadical prostatectomy via laparotomy

Classic radical prostatectomy via open retropubic approach

Sponsors

Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
45 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* The patient must have given his informed and signed consent * The patient must be insured or beneficiary of a health insurance plan * The patient is available for 24 months of follow up * Patient has localised prostate cancer * Patient is eligible for radical prostatectomy

Exclusion criteria

* The patient is participating in another study * The patient is in an exclusion period determined by a previous study * The patient is under judicial protection, under tutorship or curatorship * The patient refuses to sign the consent * It is impossible to correctly inform the patient * Patient has a contraindication for a treatment necessary for this study * Patients with psychiatric disorders

Design outcomes

Primary

MeasureTime frameDescription
Overall cost (€) of patient care60 monthsCost of surgical treatment of localized prostate cancer by radical prostatectomy (robot-assisted or conventional retropubic laparotomy) and its follow-up for 5 years. All medical resources consumed will be evaluated during the first 5 years after surgery.

Secondary

MeasureTime frameDescription
Change in erectile functionbaseline to 1 monththe International Index of Erectile Function (IIEF-15) will be used.
the % of positive margins after resectionbaseline (Day 1)
presence/absence of PSA (Prostate Specific Antigen ) > 0.2 ng/ml (recurrence)1 month
Cost (€) of surgery via micro-costingDay 1All human and material resources necessary for carrying out a prostatectomy will be evaluated.
Change in quality of life as estimated by the QLQC-30 questionnairebaseline to 1 month
Presence/absence of complications (Clavien)1 monthThe Clavien classification will be used (Clavien, P.A., Sanabria J.R., et S.M. Strasberg. 1992. Proposed classification of complications of surgery with examples of utility in cholecystectomy. Suregry 111 (5): 518-526.)
Presence/absence of complications (Pentafecta)1 monthThe Pentafecta classification will be used.
Change in function as estimated by the PR25 questionnairebaseline to 1 month

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026